Spectranetics gets US nod to test heart attack laser therapy
This article was originally published in Clinica
Executive Summary
Spectranetics is to start a US trial to test whether its excimer laser catheters can help treat heart attack patients by ablating the thrombus that is obstructing blood flow in an artery and creating the attack.